Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
Clinical trial NCT02523547 · UNKNOWN
Trial details
- NCT number
- NCT02523547
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-02-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.